ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,164.90
-0.22%
Dow Jones
40,954.48
1.85%
Gold vs US Dollar
2,469.75
1.96%
Brent Oil
83.315
-1.22%
Bitcoin
65,231.53
0.62%
Pepperstone
Advertisement
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Allos Therapeutics, Inc. (MM) (ALTH)

  7. Allos Therapeutics, Inc. (MM) (ALTH) News

Allos Therapeutics, Inc. (MM) (ALTH)

Allos Therapeutics, Inc. (MM)
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:ALTH
DateTimeSourceHeadlineSymbolCompany
20/07/201112:54Edgar (US Regulatory)Current report filing (8-K)NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
20/07/201112:52Edgar (US Regulatory)Filing of certain prospectuses and communications in connection with business combination transactions (425)NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
20/07/201112:49Edgar (US Regulatory)Filing of certain prospectuses and communications in connection with business combination transactions (425)NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
20/07/201112:48Edgar (US Regulatory)Filing of certain prospectuses and communications in connection with business combination transactions (425)NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
20/07/201112:47Edgar (US Regulatory)Filing of certain prospectuses and communications in connection with business combination transactions (425)NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
20/07/201112:46Edgar (US Regulatory)Filing of certain prospectuses and communications in connection with business combination transactions (425)NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
20/07/201112:00Business WireAMAG Pharmaceuticals and Allos Therapeutics Agree to Merge to Strengthen Commercial Portfolio and Achieve Cost SynergiesNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
13/07/201121:21Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
01/07/201122:37Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
23/06/201121:28Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
23/06/201121:27Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
23/06/201121:26Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
23/06/201121:25Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
23/06/201121:24Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
23/06/201121:23Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
23/06/201121:11Edgar (US Regulatory)Current report filing (8-K)NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
20/06/201114:30ZacksLabel Expansion for CELG's Istodax - Analyst BlogNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
17/06/201122:29Business WireData Shows Activity of FOLOTYN® in Patients with Relapsed or Refractory Peripheral T-Cell Lymphoma Following Treatment with ...NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
17/06/201114:00MarketwiredResearch Report on Allos Therapeutics, Inc. and Spectrum Pharmaceuticals, Inc. -- BioPharm Looks Forward for GrowthNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
17/06/201111:50GlobeNewswire Inc.Allos Therapeutics is MicroStockProfit.com's Biopharm Feature StockNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
17/06/201107:30Business WireData Suggests Treatment with FOLOTYN® Reverses Trend of Progressive Resistance Observed in Patients with Drug-Resistant Rela...NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
16/06/201107:30Business WireCOMPLETE Registry Provides First Glance into Treatment Patterns for Patients with Peripheral T-Cell LymphomaNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
08/06/201114:00Business WireFOLOTYN® Data to be Presented at the Congress of the European Hematology Association & the International Conference on Malig...NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
06/06/201120:57Edgar (US Regulatory)Amended Statement of Ownership (SC 13G/A)NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
20/05/201117:49ZacksRisk-Reward Balanced at Allos - Analyst BlogNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
16/05/201121:14Edgar (US Regulatory)Current report filing (8-K)NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
13/05/201117:55Zacks1Q Loss Narrows at Allos - Analyst BlogNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
10/05/201122:24Edgar (US Regulatory)Quarterly Report (10-Q)NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
10/05/201121:11Edgar (US Regulatory)Current report filing (8-K)NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
10/05/201121:05Business WireAllos Therapeutics and Mundipharma Announce Strategic Collaboration for FOLOTYNNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
 Showing the most relevant articles for your search:NASDAQ:ALTH

Your Recent History

LSE
HEAL
Ishares Hc Inno
NASDAQ
VCEL
Vericel
NASDAQ
FLGC
Flora Growth
BOV
EZTCG146
EZTCG146 Ex:14,6
Delayed Upgrade Clock
    ADVFN Logo
    InvestorsHub

    United Kingdom
    Company
    Business
    Popular
    Get The App
    App Store
    Google Play

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved